Refractory Oral Ulcer Responsive to Infliximab: A Case Report
Author:
Publisher
S. Karger AG
Subject
Otorhinolaryngology
Reference9 articles.
1. Aikawa NE, Gonçalves C, Silva CA, Gonçalves C, Bonfá E, de Carvalho JF. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet’s disease. Rheumatol Int. 2011 Aug;31(8):1097–9.
2. Jung BY, Lee SH, Chung SK, Lee CK, Lee TH, Chung IK, et al. Successful primary infliximab treatment of orofacial Crohn’s disease without gastrointestinal manifestation. Korean. Korean J Gastroenterol. 2012 Jun;59(6):437–40.
3. O’Neill ID. Efficacy of tumour necrosis factor-α antagonists in aphthous ulceration: review of published individual patient data. J Eur Acad Dermatol Venereol. 2012 Feb;26(2):231–5.
4. Ryu HJ, Seo MR, Choi HJ, Baek HJ. Infliximab for refractory oral ulcers. Am J Otolaryngol. 2014 Sep-Oct;35(5):664–8.
5. O’Neill ID. Off-label use of biologicals in the management of inflammatory oral mucosal disease. J Oral Pathol Med. 2008 Nov;37(10):575–81.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor necrosis factor alpha (TNF-α) blockage reduces acute inflammation and delayed wound healing in oral ulcer of rats;Inflammopharmacology;2022-08-10
2. Role of biologics in refractory recurrent aphthous stomatitis;Journal of Oral Pathology & Medicine;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3